PML Case Seen in Patient on Gilenya

(MedPage Today) -- A patient taking the oral multiple sclerosis drug fingolimod (Gilenya) for 7 months developed progressive multifocal leukoencephalopathy (PML), according to Novartis, the drug's manufacturer.
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news